Researchers believe that Ozempic and Wegovy, different brand names for the injectable drug ... READ ALSO: This ‘Ozempic for ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

The acquisition, announced in February, underscores Novo Nordisk’s push to boost output of its popular obesity drug Wegovy.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...

AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

also known as Mounjaro — that so far has shown even more weight loss than Wegovy. A pack of other companies are hot on both ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk, whose profits from blockbuster weight-loss ...